Insider Transactions in Q1 2025 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect |
2,000
-0.23%
|
$166,000
$83.51 P/Share
|
|
Jan 15
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-2.54%
|
$2,052,000
$76.1 P/Share
|
|
Jan 15
2025
|
James Richard Porter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+8.91%
|
$729,000
$27.85 P/Share
|
|
Jan 06
2025
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,483
-1.34%
|
$196,157
$79.38 P/Share
|
|
Jan 06
2025
|
Henry E. Pelish Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+23.09%
|
-
|
|
Jan 06
2025
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,016
-2.63%
|
$317,264
$79.38 P/Share
|
|
Jan 06
2025
|
Darlene Noci Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+26.48%
|
-
|
|
Jan 06
2025
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,016
-2.05%
|
$317,264
$79.38 P/Share
|
|
Jan 06
2025
|
Christopher Durant Turner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+21.98%
|
-
|
|
Jan 06
2025
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,964
-1.93%
|
$234,156
$79.38 P/Share
|
|
Jan 06
2025
|
Deborah Ann Miller Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+26.48%
|
-
|
|
Jan 06
2025
|
James Richard Porter President and CEO |
SELL
Open market or private sale
|
Direct |
17,301
-2.21%
|
$1,366,779
$79.38 P/Share
|
|
Jan 06
2025
|
James Richard Porter President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,250
+17.44%
|
-
|
|
Jan 06
2025
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,016
-2.07%
|
$317,264
$79.38 P/Share
|
|
Jan 06
2025
|
Alexandra Balcom Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+22.19%
|
-
|